MDSN (OTCMKTS:MDSN) is a Florida-based medical technology company specializing in the design, manufacture and distribution of non-invasive diagnostic and monitoring systems. Since its founding in 1998, the company has focused on delivering portable and stationary devices for cardiovascular, pulmonary and audiological applications. Its core product portfolio includes electrocardiogram (ECG) systems, blood pressure monitors, spirometers and diagnostic audiometers, all of which incorporate digital data management and remote connectivity features.
The company’s products are developed at its headquarters in Miami, where an in-house research and development team collaborates with clinical partners to refine device accuracy, usability and compliance with international regulatory standards. MDSN holds several patents related to sensor technology and signal-processing algorithms, and regularly updates its software platforms to support interoperability with electronic health record (EHR) systems and telemedicine services.
MDSN serves a global customer base encompassing hospitals, outpatient clinics, diagnostic labs and long-term care facilities. The company distributes its devices through direct sales in North America and Europe, and through authorized distributors in Asia Pacific and Latin America. In addition to product sales, MDSN provides installation, maintenance, calibration and training services to ensure clients meet local regulatory requirements and optimize device performance.
Under the leadership of President and CEO John A. Carter, MDSN has pursued strategic partnerships to expand its footprint in emerging markets and to integrate artificial intelligence-based decision support into its diagnostic platforms. The executive team, which includes Chief Technology Officer Maria Lopez and Chief Operating Officer David Kim, remains committed to advancing point-of-care diagnostics through targeted research investments and continuous improvement of its service offerings.
AI Generated. May Contain Errors.